No description
-
2019 (v1)PublicationUploaded on: March 27, 2023
-
2020 (v1)Publication
A novel coronavirus, currently identified as COVID-19, was recently defined as the cause of a cluster of patients with pneumonia of unknown origin that was initially reported from Wuhan, Hubei province, People's Republic of China.
Uploaded on: April 14, 2023 -
2020 (v1)Publication
In patients with hepatitis C virus (HCV) and compensated advanced chronic liver disease (cACLD) there is evidence that sustained virological response (SVR) to direct-acting antivirals (DAA) may ameliorate portal hypertension, although both the course of oesophageal varices and the performance of their non-invasive predictors following...
Uploaded on: April 14, 2023 -
2017 (v1)Publication
The Lémann Index (LI) was developed to assess the cumulative structural damage of the intestinal tract in patients with Crohn's Disease (CD) independently of clinical and biochemical activity. Recently, the goal of CD focused on obtaining mucosal healing and deep remission rather than simple symptom control. These new therapeutic aims emphasize...
Uploaded on: March 27, 2023 -
2018 (v1)Publication
Introduction: The introduction of proton pump inhibitors (PPIs) into clinical practice has greatly improved our therapeutic approach to acid-related diseases for their efficacy and safety. Areas Covered: The following evidence-based indications for PPI use are acknowledged by many scientific societies: treatment of the various forms and...
Uploaded on: March 27, 2023 -
2018 (v1)Publication
The introduction of proton-pump inhibitors (PPIs) into clinical practice since about thirty years has greatly improved our therapeutic approach to acid-related diseases for their well recognized efficacy and safety. Accordingly, the role of surgery has been enormously reduced in this field. The main indications for PPI use are universally...
Uploaded on: April 14, 2023